These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33619706)

  • 1. Expression of kisspeptin and KISS1 receptor in pituitary neuroendocrine tumours - an immunohistochemical study.
    Mihajlovic M; Pekic S; Doknic M; Stojanovic M; Miljic D; Soldatovic I; Vukotic T; Janev T; Cirovic S; Terzic T; Raicevic S; Skender-Gazibara M; Popovic V; Manojlovic-Gacic E
    Endokrynol Pol; 2021; 72(2):91-96. PubMed ID: 33619706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10.
    Martínez-Fuentes AJ; Molina M; Vázquez-Martínez R; Gahete MD; Jiménez-Reina L; Moreno-Fernández J; Benito-López P; Quintero A; de la Riva A; Diéguez C; Soto A; Leal-Cerro A; Resmini E; Webb SM; Zatelli MC; degli Uberti EC; Malagón MM; Luque RM; Castaño JP
    Eur J Endocrinol; 2011 Mar; 164(3):355-62. PubMed ID: 21169415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
    Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
    Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours.
    Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Grieve J; Dorward N; Mendoza N; Nair R; Muquit S; Grossman AB; Korbonits M
    J Neuroendocrinol; 2021 Dec; 33(12):e13052. PubMed ID: 34708902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower
    Tjörnstrand A; Casar-Borota O; Heurling K; Schöll M; Gjertsson P; Himmelman J; Itsenko O; Ragnarsson O; Filipsson Nyström H
    Clin Endocrinol (Oxf); 2020 Mar; 92(3):222-231. PubMed ID: 31868239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours.
    Øystese KAB; Casar-Borota O; Berg-Johnsen J; Berg JP; Bollerslev J
    Endocrine; 2022 Jun; 77(1):151-159. PubMed ID: 35674926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental protein expression of kisspeptin-1 (KISS1) and the kisspeptin-1 receptor (KISS1R) in pregnancy complicated by diabetes mellitus or preeclampsia.
    Kapustin RV; Drobintseva AO; Alekseenkova EN; Onopriychuk AR; Arzhanova ON; Polyakova VO; Kvetnoy IM
    Arch Gynecol Obstet; 2020 Feb; 301(2):437-445. PubMed ID: 31811415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours.
    Turchini J; Sioson L; Clarkson A; Sheen A; Gill AJ
    Endocr Pathol; 2021 Sep; 32(3):408-414. PubMed ID: 33694064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors.
    Yaron M; Renner U; Gilad S; Stalla GK; Stern N; Greenman Y
    Pituitary; 2015 Jun; 18(3):306-11. PubMed ID: 24817066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Insulinoma-Associated Protein 1 Expression in Pituitary Neuroendocrine Tumors.
    Hirokawa Y; Inomoto C; Oyama K; Tahara S; Y Osamura R; Shiomi T; Matsuno A
    Acta Histochem Cytochem; 2023 Dec; 56(6):105-110. PubMed ID: 38318099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Kiss1/Kiss1r system in the regulation of pituitary cell function.
    Gahete MD; Vázquez-Borrego MC; Martínez-Fuentes AJ; Tena-Sempere M; Castaño JP; Luque RM
    Mol Cell Endocrinol; 2016 Dec; 438():100-106. PubMed ID: 27477782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular biology of thyrotroph pituitary neuroendocrine tumors.
    Horiguchi K
    Endocr J; 2023 Feb; 70(2):135-139. PubMed ID: 36653153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of GATA-3 Expression in the Analysis of Pituitary Neuroendocrine Tumour (PitNET) Transcription Factors.
    Turchini J; Sioson L; Clarkson A; Sheen A; Gill AJ
    Endocr Pathol; 2020 Jun; 31(2):150-155. PubMed ID: 32193825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plurihormonal Pituitary Neuroendocrine Tumours - A Single Centre Experience.
    Mihajlović M; Pekić S; Doknić M; Stojanović M; Rašić D; Miljić D; Petakov M; Manojlović Gačić E
    Int J Surg Pathol; 2024 May; 32(3):470-477. PubMed ID: 37438981
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokeratin 8/18-negative somatotroph pituitary neuroendocrine tumours (PitNETs, adenomas) show variable morphological features and do not represent a clinicopathologically distinct entity.
    Soukup J; Cesak T; Hornychova H; Manethova M; Michnova L; Netuka D; Vitovcova B; Cap J; Ryska A; Gabalec F
    Histopathology; 2021 Sep; 79(3):406-415. PubMed ID: 33738859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.
    Principe M; Chanal M; Ilie MD; Ziverec A; Vasiljevic A; Jouanneau E; Hennino A; Raverot G; Bertolino P
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification.
    Dottermusch M; Schüller U; Hagel C; Saeger W
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12870. PubMed ID: 36527335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of kisspeptin and Kiss1R in the regulation of prolactin gene expression in rat somatolactotroph GH3 cells.
    Hara T; Kanasaki H; Tumurbaatar T; Oride A; Okada H; Kyo S
    Endocrine; 2019 Jan; 63(1):101-111. PubMed ID: 30255291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Kisspeptin (KISS1) and its Receptor GPR54 (KISS1R) in Prostate Cancer.
    Xoxakos I; Petraki C; Msaouel P; Armakolas A; Grigorakis A; Stefanakis S; Koutsilieris M
    Anticancer Res; 2020 Feb; 40(2):709-718. PubMed ID: 32014912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.